Pfizer wins first US trial over Zoloft | Fin24
  • Covid-19 Money Hub

    The hub will help answer your business and money questions during the coronavirus crisis.

  • Cigarettes

    The tobacco ban is a 'deal with the devil' that undermines transformation, say lobby groups.

  • Easing the Lockdown

    Liquor makers want bars to become drink-collection points when the alcohol ban lifts.


Pfizer wins first US trial over Zoloft

Apr 19 2015 12:00

St Louis - Pfizer scored a key victory Friday when it was cleared of liability in the first US trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.

Plaintiff Kristyn Pesante claimed that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects and sought damages after her son was born with a rare, serious congenital heart problem.

Following a week-long trial in St. Louis, Missouri, jurors deliberated briefly before clearing Pfizer of liability, according to a Pfizer spokesperson Neha Wadhwa. Pesante had sought both compensatory and punitive damages, accusing Pfizer of downplaying Zoloft's risks in order to boost sales.

Hundreds of lawsuits saying Zoloft can lead to cardiac and other birth defects have been filed in US state and federal courts. While not binding on the other cases, Friday's verdict is "particularly significant" because Pesante's was the first case selected by plaintiffs for trial and featured much of the same medical evidence and theories underpinning other cases across the country, Wadhwa said.

Pesante's 2012 lawsuit said that Pfizer touted Zoloft as a treatment for depression in pregnant women that had a lower risk of side effects than similar drugs. She said she took the drug during her first trimester and was not aware at the time of the risks.

But Pfizer has disputed any scientific link between Zoloft and birth defects and said that its position is supported by individual medical groups including the American Heart Association, American Psychiatric Association and American College of Obstetricians and Gynecologists.

A lawyer for plaintiffs did not immediately return requests for comment.

Approved by the US Food and Drug Administration, Zoloft is part of a widely prescribed group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs.

In 2010, GlaxoSmithKline Plc paid an undisclosed amount of money to settle some US lawsuits linking another SSRI, Paxil, to birth defects.

The next Zoloft trial is scheduled to take place later this year in state court in Philadelphia.

pfizer  |  us  |  health


Read Fin24’s Comments Policy publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

Voting Booth

How has Covid-19 impacted your financial position?

Previous results · Suggest a vote